Philips highlights MediReport capabilities before Philips stock results

Published on 10/27/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Philips stock trades at EUR 23.88 on October 27, 2026 versus the Xetra close. Q2 revenue reached EUR 4.36 billion with 4.00 percent growth.

Health technology milestones and dates

Philips highlighted MediReport 360 capabilities on October 21, 2026.
Second-quarter revenue reached EUR 4.36 billion with 4.00 percent comparable growth.
Philips stock trades at EUR 23.88 at 11:13 a.m. CEST at Lang & Schwarz on October 27, 2026, 0.21 percent above the Xetra close of October 26, 2026.
Philips will publish third-quarter 2026 results on November 3, 2026.

Philips, NL0000009538, Illustration mit AI erstellt.

Philips is trading at EUR 23.88 at Lang & Schwarz on October 27, 2026, at 11:13 a.m. CEST, 0.21 percent above the Xetra close of October 26, 2026. The latest company development is a cardiovascular informatics update linked to MediReport, which Philips highlighted on October 21, 2026, according to Simply Wall St.

MediReport adds workflow depth

The MediReport 360 platform supports structured cardiovascular documentation and real-time reporting across clinical workflows. The relevance for Philips is strategic: the company is combining imaging, information management and reporting tools rather than presenting the acquisition as a standalone product.

The market is still weighing operational quality against headline margin figures. Philips reported second-quarter 2026 revenue of EUR 4.36 billion, with comparable sales growth of 4.00 percent and an adjusted EBITA margin of 16.40 percent, according to De Belegger. The comparison is important because the same source attributed 4.20 percentage points of the margin to a US tariff refund.

Three milestones since July

Philips reported EUR 4.36 billion of second-quarter revenue on July 28, 2026. On October 9, 2026, the company formed a Sonicare clinical advisory board with 12 experts. On October 21, 2026, Philips highlighted MediReport 360 capabilities for cardiovascular informatics, according to Simply Wall St.

What does the margin signal?

The 16.40 percent adjusted EBITA margin looks stronger than the underlying operating trend because the tariff refund contributed 4.20 percentage points. That leaves execution, cost inflation and demand in China as the more important tests for durable improvement. MarketScreener reported that RBC retained a Neutral rating and a EUR 25.00 target in October 2026, while the next earnings release may provide a fresh test of that valuation view.

Upcoming reporting date

Philips will publish third-quarter 2026 results on November 3, 2026, with the release scheduled for 7:00 a.m. CET and the conference call at 10:00 a.m. CET, according to the Philips investor-relations page.

Stock stays near its yearly midpoint

The quoted EUR 23.88 sits inside the EUR 20.90 to EUR 27.70 52-week range, while the market capitalization is EUR 23.4 billion, both figures dated October 26, 2026. Philips therefore enters the results date with a modest daily move and a valuation that still leaves the quarterly margin quality as the central question.

Philips stock was trading at EUR 23.88 at Lang & Schwarz on October 27, 2026, at 11:13 a.m. CEST, 0.21 percent above the Xetra close of October 26, 2026 at EUR 23.83. The further course of trading is shown by the continuously updated real-time quote of Philips stock.